We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+7.44%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$25.3B
AUM Growth
+$2.28B
(+9.9%)
Cap. Flow
+$944M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
31.14%
Holding
1,538
New
18
Increased
913
Reduced
179
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$115M |
| 2 |
Boston Scientific
BSX
|
+$76.1M |
| 3 |
AptarGroup
ATR
|
+$51.5M |
| 4 |
Halozyme
HALO
|
+$49.1M |
| 5 |
Fluence Energy
FLNC
|
+$37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$53.5M |
| 2 |
Broadcom
AVGO
|
+$37.8M |
| 3 |
WillScot Mobile Mini Holdings
WSC
|
+$37.5M |
| 4 |
TE Connectivity
TEL
|
+$26.7M |
| 5 |
NVIDIA
NVDA
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.77% |
| 2 | Healthcare | 19.94% |
| 3 | Financials | 10.69% |
| 4 | Industrials | 8.65% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
First Merchants
FRME
$2.73B
| $466K | ﹤0.01% |
12,516
| – | – |
|
1277
Materion
MTRN
$6.01B
| $466K | ﹤0.01% |
4,166
+400
| +11% | +$44.5K |
|
1278
Addus HomeCare
ADUS
$2.2B
| $463K | ﹤0.01% |
3,483
+600
| +21% | +$75.7K |
|
1279
CarGurus
CARG
$3.36B
| $462K | ﹤0.01% |
15,400
| – | – |
|
1280
TripAdvisor
TRIP
$1.24B
| $462K | ﹤0.01% |
31,900
+12,000
| +60% | +$186K |
|
1281
Hayward Holdings
HAYW
$3.23B
| $459K | ﹤0.01% |
29,900
| – | – |
|
1282
Recursion Pharmaceuticals
RXRX
$1.79B
| $458K | ﹤0.01% |
69,500
+17,400
| +33% | +$125K |
|
1283
Helen of Troy
HELE
$700M
| $455K | ﹤0.01% |
7,351
+2,400
| +48% | +$142K |
|
1284
La-Z-Boy
LZB
$1.67B
| $455K | ﹤0.01% |
10,602
| – | – |
|
1285
Janus International
JBI
$673M
| $454K | ﹤0.01% |
44,900
-930,000
| -95% | -$10.8M |
|
1286
Enovis
ENOV
$1.41B
| $453K | ﹤0.01% |
10,517
+2,600
| +33% | +$116K |
|
|
HI
1287
DELISTED
Hillenbrand
HI
| $453K | ﹤0.01% |
16,297
+2,400
| +17% | +$84.4K |
|
1288
Tecnoglass Holdings Inc.
TGLS
$1.87B
| $453K | ﹤0.01% |
6,600
| – | – |
|
1289
Harmony Biosciences
HRMY
$2.26B
| $452K | ﹤0.01% |
11,300
+1,500
| +15% | +$52.7K |
|
|
CALY
1290
Callaway Golf Company
CALY
$2.99B
| $452K | ﹤0.01% |
41,197
| – | – |
|
1291
Vertex
VERX
$2.01B
| $451K | ﹤0.01% |
11,700
+3,200
| +38% | +$118K |
|
1292
AMN Healthcare
AMN
$1.31B
| $450K | ﹤0.01% |
10,616
+3,000
| +39% | +$157K |
|
1293
Bausch Health
BHC
$2.35B
| $449K | ﹤0.01% |
55,000
| – | – |
|
1294
BancFirst
BANF
$3.88B
| $448K | ﹤0.01% |
4,258
+500
| +13% | +$50.8K |
|
1295
DigitalOcean
DOCN
$16B
| $448K | ﹤0.01% |
11,100
| – | – |
|
|
RCM
1296
DELISTED
R1 RCM Inc. Common Stock
RCM
| $448K | ﹤0.01% |
31,600
| – | – |
|
1297
Aurinia Pharmaceuticals
AUPH
$2.02B
| $445K | ﹤0.01% |
60,700
+7,100
| +13% | +$44K |
|
1298
Oxford Industries
OXM
$545M
| $445K | ﹤0.01% |
5,126
+1,800
| +54% | +$166K |
|
|
PDCO
1299
DELISTED
Patterson Companies, Inc.
PDCO
| $443K | ﹤0.01% |
20,300
| – | – |
|
|
PPBI
1300
DELISTED
Pacific Premier Bancorp
PPBI
| $441K | ﹤0.01% |
17,523
| – | – |
|
Similar funds
VIA
Handelsbanken Fonder's Q3 2024 Portfolio in Review
As of Q3 2024, Handelsbanken Fonder held 1,538 positions worth $25.3B, up 9.9% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Handelsbanken Fonder deployed $944M of net new capital in Q3 2024, opening 18 new positions and adding to 913 existing holdings. Its largest new stake was Edison International: 24,542 shares worth $2.14M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $53.5M trimmed.
- Handelsbanken Fonder's largest Q3 2024 buy was Edison International: 24,542 shares worth $2.14M.
- Handelsbanken Fonder added most to Merck in Q3 2024, an estimated $115M increase.
- Handelsbanken Fonder's biggest Q3 2024 reduction was Edwards Lifesciences, cutting an estimated $53.5M.
- Handelsbanken Fonder fully exited TE Connectivity in Q3 2024, selling an estimated $26.7M.
- Handelsbanken Fonder's ten largest holdings make up 31% of its $25.3B portfolio in Q3 2024.
- Handelsbanken Fonder opened 18 new positions and closed 16 in Q3 2024.
- Handelsbanken Fonder's portfolio value rose 9.9% quarter-over-quarter to $25.3B.
Based on Handelsbanken Fonder's 13F filing for Q3 2024, filed 4 Oct 2024.